We describe the case of a pregnant woman, 35 weeks' gestation, with primary pulmonary hypertension and coarctation of the aorta requiring emergency Caesarean section under general anaesthesia. The patient had a pulmonary artery catheter inserted before operation which revealed pulmonary artery pressures in excess of 80/40 mm Hg. These were lowered using an infusion of glyceryl trinitrate. After delivery of the baby and administration of oxytocin, pulmonary artery pressures were more difficult to control. An infusion of prostacyclin was substituted which stabilized pulmonary pressures. After operation, she was transferred to the intensive care unit where prostacyclin was administered by an "aerosolized" route. Her trachea was extubated after 48 h and she made an uneventful recovery. (Br. J. Anaesth. 1998; 81: 790-792).
Primary pulmonary hypertension is a rare condition and in association with pregnancy can result in high maternal mortality. 1 The literature on these patients is scant and inconclusive with regard to anaesthetic management. 2 3 We describe our management of such a case, which was made more difficult by an associated coarctation of the aorta and a possible diagnosis of asthma.
Case report
A 25-yr-old multiparous woman presented to the anaesthetic department for an urgent Caesarean section with a diagnosis of severe primary pulmonary hypertension and associated mild coarctation of the aorta. Until the morning of surgery, the patient had not been seen by an anaesthetist. This was her third pregnancy, the previous two being essentially normal deliveries, apart from one episode of dyspnoea and wheezing during her second pregnancy which was treated with salbutamol inhaler. A diagnosis of asthma had been made. No further investigation of her "asthma" was undertaken at that stage. No diagnosis of primary pulmonary hypertension had been made prior to this pregnancy.
During this pregnancy the patient was noted to have a loud pansystolic murmur at the left sternal edge at a 28-week antenatal clinic. She was referred for cardiology consultation and underwent echocardiography which revealed severe pulmonary hypertension and an associated coarctation of the aorta.
Pulmonary artery pressures were in excess of 80/40 mm Hg (normal 25/10 mm Hg) and the right ventricle was dilated and hypokinetic. Although initially asymptomatic, she was admitted at 35 weeks' gestation complaining of dyspnoea with a differential diagnosis of heart failure or pneumonia. She was treated with diuretics and after a significant diuresis her clinical condition improved.
However, on the following day, she became tachycardic, tachypnoeic and on auscultation had generalized rhonchi and basal crepitations. This was associated with a decreasing 2 O a , S despite added oxygen. A chest x-ray showed increased interstitial markings. At this stage, cardiotocography tracings showed evidence of fetal distress and it was decided that, in the interest of mother and baby, urgent delivery should be effected. Induction of labour was considered inappropriate and Caesarean section was planned. The patient was admitted to the high dependency unit where an arterial cannula and pulmonary artery flotation (PAF) catheter were inserted and her cardiac indices measured (table 1) . Pulmonary artery pressures were extremely labile and fluctuated markedly with minimal stimulation, such as insertion of a peripheral cannula. An infusion of glyceryl trinitrate (GTN) was commenced at a rate of 50 mg h 91 via the PAF catheter and this was associated with a reduction in heart rate and pulmonary artery pressures, and some improvement in cardiac output (table 1 ). An infusion of epoprostenol (prostacyclin) was also prepared for use if required.
We decided to proceed under general anaesthesia and the patient was taken to the operating theatre. After preoxygenation and application of cricoid pressure, anaesthesia was induced with alfentanil 1 mg, etomidate 16 mg and succinylcholine 100 mg. isoflurane and 50% nitrous oxide in oxygen. Neuromuscular block was achieved with vecuronium.
In the peroperative period, the GTN infusion was increased sequentially up to 100 mg h 91 to maintain pulmonary artery pressures close to pre-induction values. Initially, this was achieved without a dramatic effect on the systemic circulation. Central venous pressure was maintained at 10-14 mm Hg throughout the operation. After delivery of a healthy 3000-g baby, oxytocin 5 u. were administered slowly over 2 min. It became increasing difficult to maintain control of pulmonary artery pressures without adversely affecting systemic pressures and at one stage these were similar (systemic 98/45 mm Hg vs pulmonary 96/52 mm Hg), despite adequate preload. The infusion of GTN was discontinued and an infusion of prostacyclin (epoprostenol) was started using the proximal lumen of the PAF catheter, at a rate of 2 ng kg 91 min
91
, increasing slowly to 5 ng kg 91 min
. This appeared to give selective control of pulmonary artery pressures while preserving other cardiac indices within acceptable limits (table 2) .
Surgery was completed uneventfully. After operation, the patient was admitted to the intensive care unit where artificial ventilation was continued. Shortly afterwards, vaginal bleeding became problematic which was thought to be secondary to infusion of prostacyclin. To avoid systemic effects, the route of administration of prostacyclin was changed: it was nebulized into the inspiratory limb of the ventilator (4 ml of concentrated epoprostenol (20 000 ng ml 91 ) nebulized at a rate of 3 ml h 91 ). The infusion of prostacyclin via the pulmonary catheter was gradually reduced and eventually stopped as the effects of the aerosolized drug became established. Pulmonary artery pressures remained low and vaginal bleeding stopped. Nasogastric nifedipine 30 mg was administered and the prostacyclin reduced after 24 h. During the postoperative period, the patient was sedated using an infusion of propofol and received morphine infusion for analgesia. The trachea was extubated after 48 h and she had an uneventful post-partum period.
Discussion
Primary pulmonary hypertension is uncommon. It is a disease of unknown aetiology; the pulmonary vasculature undergoes extensive remodelling, elevating pulmonary artery pressure and pulmonary vascular resistance. Primary pulmonary hypertension can occur at any age and in both sexes, but most commonly affects women in young adulthood or middle age. 4 While the literature on the management of nonpregnant patients with this condition is relatively extensive, information on the pregnant patient is scarce. The literature reports a mortality rate of 50% for vaginal delivery and approaching 100% for Caesarean section. In patients suffering from pulmonary hypertension, cardiac output from the right ventricle is critically dependent on filling pressure from the venous return and pulmonary pressure. It may be seriously impaired by minor stimuli causing increases in heart rate and pulmonary vascular resistance, or a decrease in venous return. Minor stimuli such as conversation, surgical discomfort or stress, although inconsequential to healthy individuals, may have dramatic effects. The commonest fatal sequence of events described is a minor stimulus causing a tachycardia or an increase in pulmonary vascular resistance followed by collapse that is unresponsive to treatment.
It is unclear if Caesarean section should be performed under epidural block or general anaesthesia. Roberts and Keast 1 in their review of pulmonary hypertension in pregnancy, based on two previous cases and two cases in their own experience, reported that only one patient had survived Caesarean section and this was under general anaesthesia. Regional block may cause a reduction in venous return which impairs output from the right ventricle. Reflex tachycardia may also reduce cardiac contractility during local block. Alternatively, a general anaesthetic may produce serious and unpredictable reductions in pulmonary blood flow, especially in the presence of a failing right ventricle.
Our patient presented to the anaesthetic team as an emergency on the morning of Caesarean section. She described no problems during this pregnancy and it was not until she was in extremis that she actually sought medical assistance. This may be part of the explanation as to why the severity of her condition was not realized until this late stage. Earlier presentation would have allowed a joint approach between the obstetric, cardiology and anaesthetic teams and we may have managed the anaesthetic differently. In that situation, we would have encouraged vaginal delivery under regional block, as described by Smedstad, Cramb and Morison. 5 They describe the management of eight cases of pulmonary hypertension, seven of whom had the benefit of a joint approach to management from early in pregnancy; all had vaginal deliveries and survived. The eighth case was a patient who was admitted as an emergency complaining of dyspnoea. This patient underwent general anaesthesia for Caesarean section and later died.
We decided to perform a general anaesthetic as we felt more confident that we could maintain critical filling pressures to the right ventricle and be more likely to control increases in pulmonary vascular resistances associated with intubation or surgical stimulation. Our patient showed evidence that any anxiety had an effect on her pulmonary vasculature. Our decision was only marginally influenced by coarctation of the aorta, which we felt was of minor significance.
The literature suggests that patients with pulmonary hypertension have an unpredictable response to the effects of vasoactive drugs. 6 Our patient was admitted to a high dependency unit before operation and had invasive monitoring while an infusion of GTN was started at a low rate. This effectively reduced pulmonary pressures and pulmonary vascular resistance while increasing cardiac indices. GTN is an effective pulmonary dilator with lesser effects on the systemic vasculature. It has minimal effects on the fetus and uterine activity. These properties make it the agent of first choice. An alternative agent may have been sodium nitroprusside, which would have been an effective pulmonary vasodilator but may have caused a more marked decrease in systemic pressures. The possible effects of its metabolite, cyanide, on the mother and fetus should also be considered. However, it is significant that after delivery of the infant and administration of a small dose of oxytocin, the response to GTN was less favourable and attempts at lowering pulmonary artery pressure were accompanied by unacceptable decreases in systemic arterial pressure. However, at this stage after delivery there are dramatic changes in fluid distribution and vascular resistance. We were unsure if this was an effect of oxytocin, changes in the vascular responsiveness to GTN or normal physiological changes. Substitution with prostacyclin was successful in restoring cardiovascular variables and underlines the need to prepare alternative dilator drugs. Prostacyclin was not used previously as we were concerned about its adverse haematological effects on the fetus. Prostacyclin is a potent vasodilator of all vascular beds. It causes relaxation of vascular smooth muscle by binding to its G protein-coupled receptor, activating adenylate cyclase and increasing production of cAMP. It is also a potent inhibitor of platelet aggregation, by increasing intracellular concentrations of cAMP. It has mild uterine relaxant properties. Prostacyclin has a short half-life in the circulation (2-3 min) and is hydrolysed rapidly at normal pH in the systemic circulation but not in its passage through the lungs. It has been used in intensive care in the management of primary and secondary pulmonary hypertension to improve cardiac performance and systemic oxygen delivery. 7 Our previous experience of prostacyclin in patients with acute respiratory distress syndrome suggested that an infusion via the pulmonary flotation catheter might be useful. One of the theories on the pathophysiology of pulmonary hypertension is a mismatch of thromboxane-prostacyclin ratios in the lung endothelium. 4 The prostacyclin infusion had the desired effect, lowering pulmonary pressures and improving the cardiac indices. The postoperative bleeding which we encountered was assumed to be caused by the effects of prostacyclin on platelet aggregation. This is a short-lived effect, lasting 20-30 min. By replacing it with "aerosolized" prostacyclin, pulmonary pressure was controlled with minimal systemic effects. Calcium antagonists were administered because they have been shown to increase survival of patients with pulmonary hypertension by 25%. 8 In view of the anticipated difficulties with weaning from artificial ventilation and to minimize "stress", the trachea was extubated on day 2 after operation while breathing spontaneously under sedation with propofol.
The patient was reviewed by the obstetrician and cardiologist and had an uneventful postpartum period. At 12 weeks after delivery and contrary to the strongest medical advice, the patient represented to the obstetric team, pregnant and at 4 weeks' gestation. She had a termination of pregnancy in the interest of maternal well being. The patient is still alive but complains of shortness of breath at rest.
